SHOULDER INNOVATIONS, INC. Earnings Per Share Disclosure
December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Net loss | $ | (40,359) | $ | (15,619) | |||||||
| Basic and diluted weighted average shares outstanding | 8,673,148 | 64,530 | |||||||||
| Net loss attributable to common shareholders, basic and diluted | $ | (4.65) | $ | (242.04) | |||||||
December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Series Seed | 0 | 830,786 | |||||||||
| Series A | 0 | 1,173,971 | |||||||||
| Series B | 0 | 309,956 | |||||||||
| Series C | 0 | 2,626,639 | |||||||||
| Series D | 0 | 4,240,522 | |||||||||
| Common Options | 1,459,757 | 1,334,803 | |||||||||
| Common Warrants | 43,578 | 17,827 | |||||||||
| Series Seed Warrants | 0 | 51,834 | |||||||||
| Series B Warrants | 0 | 52,410 | |||||||||
| Series D Warrants | 0 | 130,736 | |||||||||
| Total | 1,503,335 | 10,769,484 | |||||||||
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.